Clinical Trials on Subfoveal Neovascularization. in Hong Kong
Total 10 results
-
The University of Hong KongBiosensors InternationalRecruiting
-
BayerRegeneron PharmaceuticalsCompletedMyopia, PathologicalJapan, Taiwan, Hong Kong, Korea, Republic of, Singapore
-
Hoffmann-La RocheRecruitingChoroidal Neovascularization Secondary to Pathologic MyopiaKorea, Republic of, China, Australia, Singapore, Poland, France, Germany, Italy, Taiwan, Hong Kong
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
Novartis PharmaceuticalsCompletedVisual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)China, India, Thailand, Hong Kong, Korea, Republic of, Philippines
-
Quark PharmaceuticalsPfizerCompletedAge Related Macular DegenerationSpain, Korea, Republic of, Turkey, Taiwan, United States, Israel, Austria, Philippines, Denmark, Hong Kong, India
-
Novartis PharmaceuticalsCompletedPathological MyopiaGermany, India, Japan, Turkey, Austria, Switzerland, Italy, Lithuania, Hungary, France, Slovakia, United Kingdom, Korea, Republic of, Portugal, Hong Kong, Canada, Singapore, Spain, Latvia, Poland
-
Outlook Therapeutics, Inc.CompletedAge-related Macular Degeneration | Wet Macular Degeneration | Neovascular Age-related Macular DegenerationUnited States
-
VA Office of Research and DevelopmentCompletedMyocardial Infarction | Acute Renal Failure | Coronary RevascularizationUnited States